1-[5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-4-methylpentan-1-one;[3-(dimethylamino)pyrrolidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-3a,8,9,10,11,11c-hexahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2S)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2R)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(3S)-3-methylpiperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone

C122H140N30O7 — CID 159729057

IUPAC1-[5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-4-methylpentan-1-one;[3-(dimethylamino)pyrrolidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-3a,8,9,10,11,11c-hexahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2S)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2R)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(3S)-3-methylpiperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone
SMILESCc1[nH]ncc1-c1nc2c(c3c1CCCC3)C1C(C(=O)N3CCC(N(C)C)C3)=NNC1C=C2.Cc1[nH]ncc1-c1nc2ccc3[nH]nc(C(=O)N4CCC[C@H](C)C4)c3c2c2c1CCCC2.Cc1[nH]ncc1-c1nc2ccc3[nH]nc(C(=O)N4CCO[C@@H](C)C4)c3c2c2c1CCCC2.Cc1[nH]ncc1-c1nc2ccc3[nH]nc(C(=O)N4CCO[C@H](C)C4)c3c2c2c1CCCC2.Cc1[nH]ncc1/C(=N/c1ccc2[nH]nc(C(=O)CCC(C)C)c2c1)C1=CCCCC1
InChIInChI=1S/C25H31N7O.C25H28N6O.2C24H26N6O2.C24H29N5O/c1-14-18(12-26-28-14)23-17-7-5-4-6-16(17)21-19(27-23)8-9-20-22(21)24(30-29-20)25(33)32-11-10-15(13-32)31(2)3;1-14-6-5-11-31(13-14)25(32)24-22-20(29-30-24)10-9-19-21(22)16-7-3-4-8-17(16)23(27-19)18-12-26-28-15(18)2;2*1-13-12-30(9-10-32-13)24(31)23-21-19(28-29-23)8-7-18-20(21)15-5-3-4-6-16(15)22(26-18)17-11-25-27-14(17)2;1-15(2)9-12-22(30)24-19-13-18(10-11-21(19)28-29-24)26-23(17-7-5-4-6-8-17)20-14-25-27-16(20)3/h8-9,12,15,20,22,29H,4-7,10-11,13H2,1-3H3,(H,26,28);9-10,12,14H,3-8,11,13H2,1-2H3,(H,26,28)(H,29,30);2*7-8,11,13H,3-6,9-10,12H2,1-2H3,(H,25,27)(H,28,29);7,10-11,13-15H,4-6,8-9,12H2,1-3H3,(H,25,27)(H,28,29)/b;;;;26-23+/t;14-;2*13-;/m.010./s1
InChIKeyNAZTYZAELZHSCK-UCWKMKOVSA-N
MW2138.66 g/mol
LogP19.75
Rot. Bonds16

About 1-[5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-4-methylpentan-1-one;[3-(dimethylamino)pyrrolidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-3a,8,9,10,11,11c-hexahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2S)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2R)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(3S)-3-methylpiperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone

1-[5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-4-methylpentan-1-one;[3-(dimethylamino)pyrrolidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-3a,8,9,10,11,11c-hexahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2S)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2R)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(3S)-3-methylpiperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone (PubChem CID 159729057) has the molecular formula C122H140N30O7 and a molecular weight of 2138.66 g/mol. Its IUPAC name is 1-[5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-4-methylpentan-1-one;[3-(dimethylamino)pyrrolidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-3a,8,9,10,11,11c-hexahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2S)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2R)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(3S)-3-methylpiperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone.

Molecular Properties

Compound Name1-[5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-4-methylpentan-1-one;[3-(dimethylamino)pyrrolidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-3a,8,9,10,11,11c-hexahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2S)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2R)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(3S)-3-methylpiperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone
PubChem CID159729057
Molecular FormulaC122H140N30O7
Molecular Weight2138.66 g/mol
Exact Mass2137.15
IUPAC Name1-[5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-4-methylpentan-1-one;[3-(dimethylamino)pyrrolidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-3a,8,9,10,11,11c-hexahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2S)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2R)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(3S)-3-methylpiperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone
SMILESCc1[nH]ncc1-c1nc2c(c3c1CCCC3)C1C(C(=O)N3CCC(N(C)C)C3)=NNC1C=C2.Cc1[nH]ncc1-c1nc2ccc3[nH]nc(C(=O)N4CCC[C@H](C)C4)c3c2c2c1CCCC2.Cc1[nH]ncc1-c1nc2ccc3[nH]nc(C(=O)N4CCO[C@@H](C)C4)c3c2c2c1CCCC2.Cc1[nH]ncc1-c1nc2ccc3[nH]nc(C(=O)N4CCO[C@H](C)C4)c3c2c2c1CCCC2.Cc1[nH]ncc1/C(=N/c1ccc2[nH]nc(C(=O)CCC(C)C)c2c1)C1=CCCCC1
InChIInChI=1S/C25H31N7O.C25H28N6O.2C24H26N6O2.C24H29N5O/c1-14-18(12-26-28-14)23-17-7-5-4-6-16(17)21-19(27-23)8-9-20-22(21)24(30-29-20)25(33)32-11-10-15(13-32)31(2)3;1-14-6-5-11-31(13-14)25(32)24-22-20(29-30-24)10-9-19-21(22)16-7-3-4-8-17(16)23(27-19)18-12-26-28-15(18)2;2*1-13-12-30(9-10-32-13)24(31)23-21-19(28-29-23)8-7-18-20(21)15-5-3-4-6-16(15)22(26-18)17-11-25-27-14(17)2;1-15(2)9-12-22(30)24-19-13-18(10-11-21(19)28-29-24)26-23(17-7-5-4-6-8-17)20-14-25-27-16(20)3/h8-9,12,15,20,22,29H,4-7,10-11,13H2,1-3H3,(H,26,28);9-10,12,14H,3-8,11,13H2,1-2H3,(H,26,28)(H,29,30);2*7-8,11,13H,3-6,9-10,12H2,1-2H3,(H,25,27)(H,28,29);7,10-11,13-15H,4-6,8-9,12H2,1-3H3,(H,25,27)(H,28,29)/b;;;;26-23+/t;14-;2*13-;/m.010./s1
InChIKeyNAZTYZAELZHSCK-UCWKMKOVSA-N
XLogP19.75
TPSA466.44 Ų
H-Bond Donors10
H-Bond Acceptors24
Rotatable Bonds16
Heavy Atoms159
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002138.66
LogP ≤ 519.75
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze 1-[5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-4-methylpentan-1-one;[3-(dimethylamino)pyrrolidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-3a,8,9,10,11,11c-hexahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2S)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2R)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(3S)-3-methylpiperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-4-methylpentan-1-one;[3-(dimethylamino)pyrrolidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-3a,8,9,10,11,11c-hexahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2S)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2R)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(3S)-3-methylpiperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone?
The IUPAC name of 1-[5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-4-methylpentan-1-one;[3-(dimethylamino)pyrrolidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-3a,8,9,10,11,11c-hexahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2S)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2R)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(3S)-3-methylpiperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone (CID 159729057) is 1-[5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-4-methylpentan-1-one;[3-(dimethylamino)pyrrolidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-3a,8,9,10,11,11c-hexahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2S)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2R)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(3S)-3-methylpiperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone.
What is the SMILES notation for 1-[5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-4-methylpentan-1-one;[3-(dimethylamino)pyrrolidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-3a,8,9,10,11,11c-hexahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2S)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2R)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(3S)-3-methylpiperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone?
The canonical SMILES for 1-[5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-4-methylpentan-1-one;[3-(dimethylamino)pyrrolidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-3a,8,9,10,11,11c-hexahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2S)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2R)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(3S)-3-methylpiperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone is Cc1[nH]ncc1-c1nc2c(c3c1CCCC3)C1C(C(=O)N3CCC(N(C)C)C3)=NNC1C=C2.Cc1[nH]ncc1-c1nc2ccc3[nH]nc(C(=O)N4CCC[C@H](C)C4)c3c2c2c1CCCC2.Cc1[nH]ncc1-c1nc2ccc3[nH]nc(C(=O)N4CCO[C@@H](C)C4)c3c2c2c1CCCC2.Cc1[nH]ncc1-c1nc2ccc3[nH]nc(C(=O)N4CCO[C@H](C)C4)c3c2c2c1CCCC2.Cc1[nH]ncc1/C(=N/c1ccc2[nH]nc(C(=O)CCC(C)C)c2c1)C1=CCCCC1.
What is the InChIKey of 1-[5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-4-methylpentan-1-one;[3-(dimethylamino)pyrrolidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-3a,8,9,10,11,11c-hexahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2S)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2R)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(3S)-3-methylpiperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone?
The InChIKey is NAZTYZAELZHSCK-UCWKMKOVSA-N. The full InChI is InChI=1S/C25H31N7O.C25H28N6O.2C24H26N6O2.C24H29N5O/c1-14-18(12-26-28-14)23-17-7-5-4-6-16(17)21-19(27-23)8-9-20-22(21)24(30-29-20)25(33)32-11-10-15(13-32)31(2)3;1-14-6-5-11-31(13-14)25(32)24-22-20(29-30-24)10-9-19-21(22)16-7-3-4-8-17(16)23(27-19)18-12-26-28-15(18)2;2*1-13-12-30(9-10-32-13)24(31)23-21-19(28-29-23)8-7-18-20(21)15-5-3-4-6-16(15)22(26-18)17-11-25-27-14(17)2;1-15(2)9-12-22(30)24-19-13-18(10-11-21(19)28-29-24)26-23(17-7-5-4-6-8-17)20-14-25-27-16(20)3/h8-9,12,15,20,22,29H,4-7,10-11,13H2,1-3H3,(H,26,28);9-10,12,14H,3-8,11,13H2,1-2H3,(H,26,28)(H,29,30);2*7-8,11,13H,3-6,9-10,12H2,1-2H3,(H,25,27)(H,28,29);7,10-11,13-15H,4-6,8-9,12H2,1-3H3,(H,25,27)(H,28,29)/b;;;;26-23+/t;14-;2*13-;/m.010./s1.
What are the key properties of 1-[5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-4-methylpentan-1-one;[3-(dimethylamino)pyrrolidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-3a,8,9,10,11,11c-hexahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2S)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2R)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(3S)-3-methylpiperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone?
1-[5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-4-methylpentan-1-one;[3-(dimethylamino)pyrrolidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-3a,8,9,10,11,11c-hexahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2S)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2R)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(3S)-3-methylpiperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone has a molecular weight of 2138.66 g/mol, XLogP of 19.75, 16 rotatable bonds, 10 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[5-[[cyclohexen-1-yl-(5-methyl-1H-pyrazol-4-yl)methylidene]amino]-1H-indazol-3-yl]-4-methylpentan-1-one;[3-(dimethylamino)pyrrolidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-3a,8,9,10,11,11c-hexahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2S)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(2R)-2-methylmorpholin-4-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone;[(3S)-3-methylpiperidin-1-yl]-[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]methanone is sourced from PubChem (CID 159729057), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).